Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation

Journal of Perinatology volume 26, pages 667–670 (2006)Cite this article

Abstract

Objective:

To examine whether antenatal steroids (ANS), alone or with early indomethacin, are associated with spontaneous intestinal perforation (SIP). SIP is a known complication of concurrent post-natal administration of glucocorticoid and indomethacin in extremely low birth weight (ELBW) infants.

Study design:

A large de-identified national data set was retrospectively examined for infants with SIP without any report of other malformation or necrotizing entrocolitis. A control group was then derived matching for gender and birth weight (±20?g). Pre- and post-natal variables were tested by both univariate and multivariate analysis to identify associations with SIP.

Results:

From January 1996 to June 2004, there were 2?27?711 discharges from Pediatrix neonatal intensive care unit sites. From this population 388 infants with SIP associated with ELBW were compared to matched controls. Infants with SIP were more likely to have received early indomethacin and to have received a combination of early indomethacin with post-natal glucocorticoids (P<0.05 for both). When used alone (without subsequent indomethacin), ANS showed no association with SIP. When used in conjunction with indomethacin, ANS did not increase the rate of SIP beyond indomethacin alone.

Conclusion:

ELBW Infants that acquire SIP were more likely to have been exposed to early indomethacin and post-natal glucocorticoids. However, no association was found between SIP and ANS within a well-powered cohort.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Liggins GC, Howie RN . A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–525.

    CAS  Google Scholar 

  2. Crowley P . Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Reviews 2006, Issue 3. Art No: CD000065. doi:10.1002/14651858.CD00065.pub2.

  3. Papageorgiou AN, Desgranges MF, Masson M, Colle E, Shatz R, Gelfand MM . The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics 1979; 63: 73–79.

    CAS  PubMed  Google Scholar 

  4. Gamsu HR, Mullinger BM, Donnai P, Dash CH . Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol 1989; 96: 401–410.

    Article  CAS  Google Scholar 

  5. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations. J Perinatol 2006; 26: 185–188.

    Article  CAS  Google Scholar 

  6. Gordon P, Rutledge J, Sawin R, Thomas S, Woodrum D . Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol 1999; 19: 573–577.

    Article  CAS  Google Scholar 

  7. Gordon PV, Price WA, Stiles AD . Dexamethasone administration to newborn mice alters mucosal and muscular morphology in the ileum and modulates IGF-I localization. Pediatr Res 2001; 49: 93–100.

    Article  CAS  Google Scholar 

  8. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 95–101.

    Article  CAS  Google Scholar 

  9. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649–1657.

    Article  Google Scholar 

  10. Gordon PV . Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction. Pediatrics 2005; 115: 1446–1447.

    Article  Google Scholar 

  11. Watterberg K . Author reply. Pediatrics 2005; 115: 1447.

    Article  Google Scholar 

  12. Gordon PV . Postnatal dexamethasone for lung disease of prematurity. N Engl J Med 2004; 350: 2715–2718.

    Article  Google Scholar 

  13. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26: 93–99.

    Article  CAS  Google Scholar 

  14. Gordon PV, Moats-Staats BM, Stiles AD, Price WA . Dexamethasone changes the composition of insulin-like growth factor binding proteins in the newborn mouse ileum. J Pediatr Gastroenterol Nutr 2002; 35: 532–538.

    Article  CAS  Google Scholar 

  15. Gordon PV, Price WA, Stiles AD, Rutledge JC . Early postnatal dexamethasone diminishes transforming growth factor alpha localization within the ileal muscularis propria of newborn mice and extremely low-birth-weight infants. Pediatr Dev Pathol 2001; 4: 532–537.

    Article  CAS  Google Scholar 

  16. Gordon PV, Marshall DD, Stiles AD, Price WA . The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: from the baby's bowel to the researcher's bench. Mol Genet Metab 2001; 72: 91–103.

    Article  CAS  Google Scholar 

  17. Lee DK, Stern M, Solomon S . Cytoplasmic glucocorticoid receptors in the developing small intestine of the rabbit fetus. Endocrinology 1976; 99: 379–388.

    Article  CAS  Google Scholar 

  18. Hundertmark S, Buhler H, Fromm M, Kruner-Gareis B, Kruner M, Ragosch V et al. Ontogeny of 11beta-hydroxysteroid dehydrogenase: activity in the placenta, kidney, colon of fetal rats and rabbits. Horm Metab Res 2001; 33: 78–83.

    Article  CAS  Google Scholar 

  19. Claus R, Raab S, Lacorn M . Activities of 11beta-hydroxysteroid dehydrogenase 2 in different regions of the intestinal tract of pigs. Exp Clin Endocrinol Diabetes 2001; 109: 374–377.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Virginia, Charlottesville, VA, USA

    J T Attridge & P V Gordon

  2. Pediatrix Medical Group, Inc, Sunrise, FL, USA

    R Clark

Authors
  1. J T Attridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P V Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P V Gordon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Attridge, J., Clark, R. & Gordon, P. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol 26, 667–670 (2006). https://doi.org/10.1038/sj.jp.7211589

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211589

Keywords

This article is cited by

Search

Advanced search

Quick links